Free Trial

Psyence Biomedical (PBMWW) Competitors

$0.01 0.00 (-12.67%)
As of 08:10 AM Eastern

PBMWW vs. ATNFW, LBPSW, AEHAW, AIMDW, ALVOW, ACABW, BFRIW, BTMDW, BCTXW, and CELUW

Should you be buying Psyence Biomedical stock or one of its competitors? The main competitors of Psyence Biomedical include 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Alvotech (ALVOW), Atlantic Coastal Acquisition Corp. II (ACABW), Biofrontera (BFRIW), biote (BTMDW), BriaCell Therapeutics (BCTXW), and Celularity (CELUW). These companies are all part of the "pharmaceutical products" industry.

Psyence Biomedical vs.

Psyence Biomedical (NASDAQ:PBMWW) and 180 Life Sciences (NASDAQ:ATNFW) are both manufacturing companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, dividends, community ranking, valuation, profitability, risk, earnings, institutional ownership and media sentiment.

Company Net Margins Return on Equity Return on Assets
Psyence BiomedicalN/A N/A N/A
180 Life Sciences N/A N/A N/A

In the previous week, Psyence Biomedical's average media sentiment score of 0.00 equaled 180 Life Sciences'average media sentiment score.

Company Overall Sentiment
Psyence Biomedical Neutral
180 Life Sciences Neutral

Psyence Biomedical and 180 Life Sciences both received 0 outperform votes by MarketBeat users.

CompanyUnderperformOutperform
Psyence BiomedicalN/AN/A
180 Life SciencesN/AN/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Psyence BiomedicalN/AN/AN/AN/AN/A
180 Life SciencesN/AN/AN/AN/AN/A

Summary

Psyence Biomedical and 180 Life Sciences tied by winning 0 of the 0 factors compared between the two stocks.

Get Psyence Biomedical News Delivered to You Automatically

Sign up to receive the latest news and ratings for PBMWW and its competitors with MarketBeat's FREE daily newsletter.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

PBMWW vs. The Competition

MetricPsyence BiomedicalPharmaceutical Preparations IndustryManufacturing SectorNASDAQ Exchange
Market CapN/A$6.57B$2.24B$9.13B
Dividend YieldN/A2.96%2.62%4.00%
P/E RatioN/A10.0127.5617.53
Price / SalesN/A315.79139.13134.21
Price / CashN/A22.63N/A32.90
Price / BookN/A5.082.024.69
Net IncomeN/A$154.90M$165.18M$224.57M
7 Day PerformanceN/A1.33%1.44%1.69%
1 Month PerformanceN/A1.52%2.64%5.34%
1 Year PerformanceN/A4.60%8.21%21.47%

Psyence Biomedical Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
PBMWW
Psyence Biomedical
N/A$0.01
-12.7%
N/AN/A$0.00N/A0.00N/AGap Down
ATNFW
180 Life Sciences
N/A$0.01
+3.0%
N/A+71.2%$0.00N/A0.007Positive News
Gap Down
LBPSW
4D pharma
N/AN/AN/AN/A$0.00$522,000.000.00N/A
AEHAW
Aesther Healthcare Acquisition
N/A$0.03
-7.3%
N/A+3.8%$0.00N/A0.002Gap Down
AIMDW
Ainos
N/A$0.19
+11.8%
N/A+8.3%$0.00$40,633.000.0040Positive News
Gap Down
ALVOW
Alvotech
N/A$3.06
-7.3%
N/A-1.5%$0.00$391.87M0.004News Coverage
Positive News
Gap Up
ACABW
Atlantic Coastal Acquisition Corp. II
N/A$0.06
-23.5%
N/AN/A$0.00N/A0.004Gap Up
BFRIW
Biofrontera
N/A$0.09
+1.4%
N/AN/A$0.00$35.36M0.0070Positive News
BTMDW
biote
N/A$0.41
-16.3%
N/AN/A$0.00$193.06M0.00N/AGap Down
BCTXW
BriaCell Therapeutics
N/A$0.18
+11.6%
N/A-93.5%$0.00N/A0.008Positive News
Gap Down
CELUW
Celularity
N/A$0.03
-1.8%
N/A+39.3%$0.00$48.20M0.00220Positive News

Related Companies and Tools


This page (NASDAQ:PBMWW) was last updated on 1/22/2025 by MarketBeat.com Staff
From Our Partners